KDOAM-25
KDOAM-25 is a potent and highly selective histone lysine demethylases 5 (KDM5) inhibitor with IC50s of 71 nM, 19 nM, 69 nM, 69 nM for KDM5A, KDM5B, KDM5C, KDM5D, respectively. KDOAM-25 increases global H3K4 methylation at transcriptional start sites and impairs proliferation in multiple myeloma MM1S cells[1].
Product Specifications
CAS Number
2230731-99-2
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/KDOAM-25.html
Solubility
10 mM in DMSO
Smiles
NC(C1=CC=NC(CNCC(N(CC)CCN(C)C)=O)=C1)=O
Molecular Formula
C15H25N5O2
Molecular Weight
307.39
References & Citations
[1]Tumber A, et al. Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells. Cell Chem Biol. 2017 Mar 16;24 (3) :371-380.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
KDM5
Citation 01
Clin Transl Med. 2024 Jun;14 (6) :e1692.|University of Gothenburg. 2023 Jun 27.|bioRxiv. 2024 October 03.|Cancer Sci. 2018 Nov;109 (11) :3602-3610.|Clin Exp Med. 2025 Nov 25;26 (1) :33.|Nat Cell Biol. 2024 Feb;26 (2) :263-277.|Research Square Preprint. 2023 Dec 2.|Sci Adv. 2025 Jun 6;11 (23) :eadu2695.
More Discoveries
Explore Other Products
Browse additional items from our catalog
9099-biotin-01 0.02 mg
SARS-CoV-2 (COVID-19) Nucleocapsid Antibody (biotin)
Sign In for Pricing
View Details